Is Now a Good Time to Buy Ocugen? [The Motley Fool]
Ocugen, Inc. (OCGN)
Company Research
Source: The Motley Fool
Prosper Junior Bakiny(TMFPBakiny)Author BioA Fool since 09, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.Key PointsIn the coronavirus vaccine market, several players -- includingModernaPfizerNASDAQ:OCGNLike many othermeme stocksYChartsGood news from IndiaOn Oct. , shares of Ocugen ended the day up by nearly 0% after India's Subject Expert CommitteegrantedNow, Ocugen and Bharat Biotech are awaiting emergency use listing for their candidate from the World Health Organization (WHO). This vote of confidence from the WHO wouldn't make the vaccine marketable everywhere, but those inoculated with products listed by the organization are generally able to travel internationally without needing to quarantine or face other restrictions. U.S.
Show less
Read more
Impact Snapshot
Event Time:
OCGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCGN alerts
High impacting Ocugen, Inc. news events
Weekly update
A roundup of the hottest topics
OCGN
News
- Biggest stock movers today: FDX, NKE, and more [Seeking Alpha]Seeking Alpha
- Ocugen hits a 52-week high after decision to lower quorum requirement [Seeking Alpha]Seeking Alpha
- Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues [Seeking Alpha]Seeking Alpha
- Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical OfficerGlobeNewswire
OCGN
Earnings
- 11/9/23 - Beat
OCGN
Analyst Actions
- 2/22/24 - HC Wainwright
OCGN
Sec Filings
- 3/21/24 - Form 8-K
- 3/20/24 - Form 3
- 3/20/24 - Form 3
- OCGN's page on the SEC website